Griffith University logo
Assoc Prof Kate Seib

Assoc Prof

Kate Seib

Principal Research Fellow
Institute for Glycomics
+61 (0)7 5552 7453 (Work)
G25 3.58, Gold Coast Campus

Are you Kate Seib?

Edit your profile


Associate Professor Seib's research is focused on understanding the processes involved in host colonisation and disease, with the aim to identify therapeutic targets of mucosal pathogens including Neisseria gonorrhoeae (causes the sexually transmitted infection gonorrhea, which can lead to infertility), Neisseria meningitidis (causes sepsis and meningitis), and Moraxella catarrhalis and Haemophilus influenzae (cause middle ear infections and exacerbations of chronic obstructive pulmonary disease). A/Prof Seib completed a PhD in microbiology in 2004 from the University of Queensland (Brisbane, Australia) and worked briefly as a Postdoctoral Researcher in Australia, followed by 6.5 years at Novartis Vaccines (Siena, Italy) as a Postdoctoral Fellow and Project Leader. During this time she developed a strong understanding of industry, vaccine development, and team management. She was part of the team working on the serogroup B meningococcal vaccine (Bexsero) that was licensed in Europe, Australia and the USA in 2013. A/Prof returned to Australia in late 2012 and is a Group Leader and Associate Director (Research) at the Institute for Glycomics. The Institute for Glycomics is a flagship biomedical research institute at Griffith University's Gold Coast campus. The purpose-designed building is located adjacent to the new Gold Coast University Hospital and is an integral component of the emerging Gold Coast Health and Knowledge Precinct, making it ideally situated for translational research, clinical trials and research training. The Institute's advantage is its focused approach to drug, vaccine and diagnostic technology discovery and development using its world-leading scientific expertise and a unique multidisciplinary approach. A/Prof was awarded an Australian National Health and Medical Research (NHMRC) Career Development Fellowship in 2013 and has additional funding from NHMRC Project Grants, NIH and Philanthropic organisations. Her group currently consists of 4 Postdoctoral Researchers, 1 PhD, 1 Masters and 1 Honours Students and several undergraduate work-experience students. Within the Institute she is a member of the Research and Research Training Committee and is a Higher Degree Research Convenor, responsible for guiding PhD students through their PhD program. A/Prof is actively involved in several professional activities. She is the current Vice President (Scientific Affairs) of the Australian Society for Microbiology (ASM), an ASM Fellow (FASM), an Associate Editor for the journals Scientific Reports, and BMC Microbiology, and a regular reviewer of manuscripts and grant applications for various journals and international granting bodies. Dr Seib also regularly participates in community activities to increase interest in Science (e.g., the Gold Coast Kids' S.T.E.M. Convention; Griffith Science on the GO! - Annual Science & Engineering Challenges; Griffith University Mentoring Program; Gold Coast Science Fair).


  • Associate Director (Research)
    Institute for Glycomics, Australia2019
  • Principal Research Fellow / Associate Professor
    Institute for Glycomics, Australia2018
  • Member
    Institute for Glycomics, Australia2012


  • Postdoctoral Research Fellow
    University of Queensland, Microbiology Department, Brisbane, Australia2004 - 2006


  • Postdoctoral Fellow
    Novartis Vaccines, Siena, Italy2006 - 2011
  • Project Leader
    Novartis Vaccines, Siena, Italy2011 - 2012


  • BSc Bachelor of Science
    University of Queensland1996 - 1998
  • Bachelor Of Science With Honours
    University of Queensland1999 - 1999
  • Doctor Of Philosophy
    University of Queensland2000 - 2004


  • Italian
    Can speak and understand